Skip to main content
Caplight Logo









Germitec

Germitec

Private
BordeauxHealthcare & Life Scienceshttps://www.germitec.com

Last Round

Series B

Feb 12, 2025

Total Funding Raised

$68.6M

Company Overview

Germitec is a medical devices company that provides UV-C technology for High-Level Disinfection (HLD) of ultrasound probes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

high-level disinfectionHLDUV-C disinfectionultrasound probe disinfectioninfection controlprobe reprocessingchemical-free disinfectionautomated disinfectionUV sterilizermedical devicehealthcare-associated infectionsHAIsdigital traceabilityMedTechTEE probes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Germitec Comparables

Compare Germitec with similar companies based on industry and business-model similarity.

Germitec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CS Medical, LLC
81%
Nanosonics Limited
80%
Lumicare
79%

Germitec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 12, 2025
DebtNov 14, 2023
Series AMay 10, 2022

Key People

Founding team and executive leadership

Jose Da Gloria

Deputy Chief Executive Officer

Executive Team

Germitec Investors

Notable investors and investment history

Germitec investors
InvestorRounds
European Investment Bank GroupDebt
Aquiti GestionSeries A
Galia GestionSeries A
EurazeoSeries B
Kurma PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2025

    Commercial launch of Chronos Max announced.

  • Jun 3, 2025

    Will attend the APIC 2025 Annual Conference.

Germitec Filings

Explore SEC and related filing metadata, where available.

Germitec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Germitec's valuation, stock price, and market status.

Is Germitec a public or private company?

Germitec is a private company.

What is the current stock price of Germitec?

Germitec is a private company with no public stock price. Caplight tracks Germitec's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Germitec worth (valuation)?

Valuation information for Germitec is not publicly available.

Can I buy Germitec stock?

Germitec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Germitec's last funding round?

Germitec's most recent funding round was Series B on February 12, 2025.

Who are the main investors in Germitec?

Key investors in Germitec include European Investment Bank Group, Eurazeo.

Will Germitec IPO soon?

No public IPO plans have been announced for Germitec.

How can I track Germitec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Germitec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBordeaux
Employee Range66
Year Founded2005
Last FundingFeb 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?